United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi consumer healthcare - promethazine hydrochloride - solution for injection - 25mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - promethazine hydrochloride 25 mg/ml - solution for injection - 25 mg/ml - active: promethazine hydrochloride 25 mg/ml

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - promethazine hydrochloride - solution for injection - promethazine hydrochloride 25 mg/ml - antihistamines for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

may & baker limited - promethazine hydrochloride - solution for injection - 25 mg/ml

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - promethazine hydrochloride 25 mg in 1 ml - phenergan injection is indicated for the following conditions: - amelioration of allergic reactions to blood or plasma. - in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - for sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - active treatment of motion sickness. - prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - as an adjunct to analgesics for the control of postoperative pain. - preoperative, postoperative, and obstetric (during labor) sedation. - intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. phenergan injection is contraindicat

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - phenergan injection is indicated for the following conditions: - amelioration of allergic reactions to blood or plasma. - in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - for sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - active treatment of motion sickness. - prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - as an adjunct to analgesics for the control of postoperative pain. - preoperative, postoperative, and obstetric (during labor) sedation. - intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. phenergan injection is contraindicated for use in pediatric patients less than two years of age due to the risk of respiratory depression ( see  warnings - respiratory depression) . phenergan injection is contraindicated in comatose states. under no circumstances should phenergan injection be given by intra-arterial injection due to the likelihood of severe arteriospasm and the possibility of resultant gangrene (see warnings - severe tissue injury, including gangrene). phenergan injection should not be given by the subcutaneous route because evidence of chemical irritation has been noted, and necrotic lesions have resulted following subcutaneous injection. the preferred parenteral route of administration is by deep intramuscular injection. phenergan injection is contraindicated in patients who have demonstrated an idiosyncratic reaction or hypersensitivity to promethazine or other phenothiazines.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - phenergan injection is indicated for the following conditions: - amelioration of allergic reactions to blood or plasma. - in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - for sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - active treatment of motion sickness. - prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - as an adjunct to analgesics for the control of postoperative pain. - preoperative, postoperative, and obstetric (during labor) sedation. - intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. phenergan injection is contraindicat

Israel - English - Ministry of Health

bio-med - j.r ltd, israel - promethazine as hydrochloride - solution for injection - promethazine as hydrochloride 25 mg / 1 ml - promethazine - phenergan is indicated :as symptomatic treatment for allergic conditions of the upper respiratory tract and skin including allergic rhinitis, urticaria and anaphylactic reactions to drugs and foreign proteins.for sedation and treatment of insomnia in adults.as an adjunct in preoperative sedation in surgery and obstetrics.as a paediatric sedative. for prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery.

Namibia - English - Namibia Medicines Regulatory Council

aventis pharma (pty) ltd - promethazine hcl - injection - promethazine hcl injection 25mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - promethazine hydrochloride - solution for injection - 2.5 %w/v